急性胰腺炎患者血浆miR-21-3p与miR-551-5p的表达及其临床意义
该前瞻性观察研究纳入海南省第三人民医院2017年1月1日至2019年12月31日收治的164例急性胰腺炎(AP)患者(轻症72例、中重症47例、重症45例)及50名健康对照,检测入院次日空腹血浆miR-21-3p和miR-551-5p表达。AP组两项指标均显著高于对照组,且随病情加重逐渐升高,重症组显著高于中重症组和轻症组。两项联合诊断重症急性胰腺炎的AUC为0.898,高于单项的0.820和0.806;联合预测重症患者死亡的AUC为0.933,高于单项的0.856和0.816。
要点
- AP患者血浆miR-21-3p和miR-551-5p随病情加重逐渐升高,重症组显著高于中重症组和轻症组(均P<0.01)。
- 两项联合诊断重症急性胰腺炎AUC 0.898(95%CI 0.841-0.960),高于miR-21-3p单项0.820和miR-551-5p单项0.806(均P<0.05),敏感度90.7%、特异度85.0%。
- 重症患者中死亡组两项指标显著高于存活组(均P<0.01)。
- 两项联合预测重症患者死亡AUC 0.933(95%CI 0.875-0.996),高于单项0.856和0.816(均P<0.05),敏感度95.2%、特异度87.5%。
- 重症患者血浆miR-21-3p与miR-551-5p表达呈正相关(r=0.827,P<0.001)。
适用人群与场景
- 2017年1月1日至2019年12月31日海南省第三人民医院收治的急性胰腺炎患者,按病情分为轻症、中重症和重症三组。
- 同期50名健康人作为对照组。
研究设计与关键结果
- 前瞻性观察研究,纳入164例AP患者(轻症72例、中重症47例、重症45例)及50名健康对照,入院次日采集空腹静脉血,实时定量PCR检测血浆miR-21-3p和miR-551-5p,终点为康复、出院或死亡。
- AP组两项指标均显著高于对照组:miR-21-3p(2-ΔΔCt)2.17±0.90 vs. 0.65±0.12,miR-551-5p(2-ΔΔCt)1.80±0.73 vs. 0.42±0.08,均P<0.01。
- 两项指标随病情加重逐渐升高(F值分别为11.635、10.204,均P<0.01);重症组显著高于中重症组和轻症组:miR-21-3p 3.16±1.08 vs. 1.85±0.71、1.70±0.64,miR-551-5p 2.63±0.95 vs. 1.52±0.46、1.36±0.40,均P<0.01。
- 重症患者中存活27例、死亡18例,轻症和中重症组无死亡;死亡组两项指标显著高于存活组:miR-21-3p 3.75±1.17 vs. 2.66±0.87,miR-551-5p 3.17±1.04 vs. 2.24±0.83,均P<0.01。
- 联合诊断重症急性胰腺炎AUC 0.898(95%CI 0.841-0.960),高于miR-21-3p单项0.820(95%CI 0.763-0.882)和miR-551-5p单项0.806(95%CI 0.748-0.867)(Z1=4.480,Z2=4.916,均P<0.05),敏感度90.7%、特异度85.0%。
- 联合预测重症患者死亡AUC 0.933(95%CI 0.875-0.996),高于miR-21-3p单项0.856(95%CI 0.794-0.917)和miR-551-5p单项0.816(95%CI 0.759-0.874)(Z1=4.395,Z2=5.520,均P<0.05),敏感度95.2%、特异度87.5%。
- 重症患者血浆miR-21-3p与miR-551-5p表达呈正相关(r=0.827,P<0.001)。
证据类型、等级与局限
- 证据类型:前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为血浆miR-21-3p和miR-551-5p表达升高与AP患者病情严重程度正相关,两项联合对重症急性胰腺炎的诊断和预后评估价值更好。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the diagnostic and diagnostic values of plasma microRNA-21-3p (miR-21-3p) and miR-551-5p expression in patients with acute pancreatitis (AP).
METHODS: A prospective observational study was conducted. AP patients admitted to the Third People's Hospital of Hainan Province from January 1st 2017 to December 31st 2019 were enrolled. The patients were divided into mild acute pancreatitis (MAP) group, moderate severe acute pancreatitis (MSAP) group and severe acute pancreatitis (SAP) group according to their severity. Fasting venous blood was collected from all subjects the day after admission, and real-time quantitative polymerase chain reaction (PCR) as used to detect the expression levels of plasma miR-21-3p and miR-551-5p. Rehabilitation, discharge or death were end points of study. In addition, 50 healthy people in the same period were selected as the control group. The receiver operating characteristic (ROC) curve was used to analyze the value of the expression levels of plasma miR-21-3p and miR-551-5p for the diagnosis and prognosis of SAP. Pearson correlation was used to analyze the relationship between the expressions of miR-21-3p and miR-551-5p in SAP patients.
RESULTS: A total of 164 AP patients were enrolled, including 72 MAP patients, 47 MSAP patients and 45 SAP patients. Among the SAP patients, 27 cases survived and 18 cases died. There were no deaths in MAP group and MSAP group. The levels of plasma miR-21-3p and miR-551-5p in AP group were significantly higher than those in control group [miR-21-3p (2-ΔΔCt): 2.17±0.90 vs. 0.65±0.12, miR-551-5p (2-ΔΔCt): 1.80±0.73 vs. 0.42±0.08, both P < 0.01]. The expression levels of plasma miR-21-3p and miR-551-5p in AP patients increased gradually with the aggravation of the disease (F values were 11.635, 10.204 respectively, both P < 0.01), and the expression levels of plasma miR-21-3p and miR-551-5p in SAP group were significantly higher than those in MSAP group and MAP group [miR-21-3p (2-ΔΔCt): 3.16±1.08 vs. 1.85±0.71, 1.70±0.64; miR-551-5p (2-ΔΔCt): 2.63±0.95 vs. 1.52±0.46, 1.36±0.40; all P < 0.01]. ROC curve analysis showed that the area under the ROC curve (AUC) and 95% confidence interval (95%CI) of the joint diagnosis of SAP with miR-21-3p and miR-551-5p were significantly higher than that of miR-21-3p or miR-551-5p alone [0.898 (0.841-0.960) vs. 0.820 (0.763-0.882), 0.806 (0.748-0.867), Z1 = 4.480, Z2 = 4.916, both P < 0.05], and the sensitivity was 90.7% and the specificity was 85.0%. The expression levels of plasma miR-21-3p and miR-551-5p in the death group of SAP patients were significantly higher than those in the survival group [miR-21-3p (2-ΔΔCt): 3.75±1.17 vs. 2.66±0.87, miR-551-5p (2-ΔΔCt): 3.17±1.04 vs. 2.24±0.83, both P < 0.01]. ROC curve analysis showed that the AUC and 95%CI of the combined prediction of death in SAP patients with miR-21-3p and miR-551-5p were significantly higher than that of miR-21-3p or miR-551-5p alone [0.933 (0.875-0.996) vs. 0.856 (0.794-0.917), 0.816 (0.759-0.874), Z1 = 4.395, Z2 = 5.520, both P < 0.05], and the sensitivity was 95.2% and the specificity was 87.5%. Correlation analysis showed a positive correlation between the expression level of plasma miR-21-3p and miR-551-5p in SAP patients (r = 0.827, P < 0.001).
CONCLUSIONS: The increased expression of plasma miR-21-3p and miR-551-5p are positively correlated with the severity of AP patients. The combination of the two items has a better value in the diagnosis and prognosis evaluation of SAP.
参考来源
- Wu K, Wang L, Fu G, et al. [Expression and clinical significance of microRNA-21-3p and microRNA-551-5p in patients with acute pancreatitis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32527354. doi:10.3760/cma.j.cn121430-20200116-00134
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。